MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
| hmdb:HMDB0057455 AOPKSFQJPHZVHJ-LVANXLMZSA-N | CL(16:1(9Z)/18:0/18:1(11Z)/18:1(11Z)) (2R)-3-{[(2R)-2,3-bis[(11Z)-octadec-11-enoyloxy]propoxy(hydroxy)phosphoryl]oxy}-2-hydroxypropoxy((2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(octadecanoyloxy)propoxy)phosphinic acid 1'-[1-(9Z-Hexadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho],3'-[1,2-di(11Z-octadecenoyl)-rac-glycero-3-phospho]-glycerol 1'-[1-Palmitoleoyl-2-stearoyl-sn-glycero-3-phospho],3'-[1,2-divaccenoyl-rac-glycero-3-phospho]-glycerol CL(1'-[16:1(9Z)/18:0],3'-[18:1(11Z)/18:1(11Z)]) CL(16:1/18:0/18:1/18:1) CL(70:3) Cardiolipin(16:1/18:0/18:1/18:1) Cardiolipin(70:3) [(2R)-3-({[(2R)-2,3-bis[(11Z)-octadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy][(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(octadecanoyloxy)propoxy]phosphinic acid |
SLM:000532039 slm:000532039 AOPKSFQJPHZVHJ-LWMPEMGFSA-L | Cardiolipin (16:1(9Z)/18:0/18:1(11Z)/18:1(11Z)) 1'-[1-(9Z-hexadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho],3'-[1,2-di-(11Z-octadecenoyl)-sn-glycero-3-phospho]-glycerol CL (16:1(9Z)/18:0/18:1(11Z)/18:1(11Z)) |
hmdb:HMDB57455 | secondary/obsolete/fantasy identifier |